NCT00233467

Brief Summary

The main purpose is to show the percentage of patients taking antipsychotics with PTSD by looking at approximately ten year's worth of data from 1994 through 2004. We will also determine the type and dose of antipsychotics the patients received, and to determine how many of those patients had psychotic versus nonpsychotic symptoms. We will be obtaining this data from the VISN 7 Corporate Data Warehouse. We hypothesize that there has been an overall increase in antipsychotic use in patient's with PTSD over the last 10 years.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Sep 2005

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2005

Completed
29 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2005

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2005

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

October 3, 2005

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 5, 2005

Completed
Last Updated

September 14, 2017

Status Verified

September 1, 2017

Enrollment Period

29 days

First QC Date

October 3, 2005

Last Update Submit

September 12, 2017

Conditions

PTSDPosttraumatic Stress Disorder

Keywords

antipsychoticsPTSDposttraumatic stress disorder

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Chart review of Veterans on antipsychotics

You may qualify if:

  • Have a diagnosis of PTSD (309.81)
  • Male or female patients at least 19 years of age

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tuscaloosa VA Medical Center

Tuscaloosa, Alabama, 35404, United States

Location

Related Publications (1)

  • Kozaric-Kovacic D, Pivac N, Muck-Seler D, Rothbaum BO. Risperidone in psychotic combat-related posttraumatic stress disorder: an open trial. J Clin Psychiatry. 2005 Jul;66(7):922-7. doi: 10.4088/jcp.v66n0716.

    PMID: 16013909BACKGROUND

MeSH Terms

Conditions

Stress Disorders, Post-Traumatic

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental Disorders

Study Officials

  • Rebecca Seamans, PharmD

    Tuscaloosa Veterans Affairs Medical Center

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
ACSO for Research

Study Record Dates

First Submitted

October 3, 2005

First Posted

October 5, 2005

Study Start

September 1, 2005

Primary Completion

September 30, 2005

Study Completion

September 30, 2005

Last Updated

September 14, 2017

Record last verified: 2017-09

Locations

US(1)